A randomised, parallel group, open trial examining the safety, efficacy and tolerability of fast titration, 800mg/day by day 4, of quetiapine fumarate compared to standard titration, 400mg/day by day 4, in the treatment of Bipolar 1 Manic episode - FATIMA.
Study identifier:D1441L00022
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomised, parallel group, open trial examining the safety, efficacy and tolerability of fast titration, 800mg/day by day 4, of quetiapine fumarate compared to standard titration, 400mg/day by day 4, in the treatment of Bipolar 1 Manic episode - FATIMA.
Medical condition
schizophrenia
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 2004
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
